Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma

References

• Weller M, Cloughesy T, Perry JR, Wick W. Standards of care for treatment of recurrent glioblastoma—are we there yet? Neuro Oncol. 2013;15(1):4–27. doi:10.1093/neuonc/nos27323136223
   PubMed Web of Science ®Google Scholar
• Stupp R, Weller M, Belanger K, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med. 2005;10.
   Web of Science ®Google Scholar
• Dhermain F. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches. Chinese Journal of Cancer. 2014;33(1):16–24. doi:10.5732/cjc.013.1021724384237
   PubMedGoogle Scholar
• Wen PY. Malignant Gliomas in Adults. N Engl J Med. 2008;16.
   Google Scholar
• de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. 2015;17(6):776–783. doi:10.1093/neuonc/nou28325313193
   PubMed Web of Science ®Google Scholar
• Pinel S, Thomas N, Boura C, Barberi-Heyob M. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Deliv Rev. 2019;138:344–357. doi:10.1016/j.addr.2018.10.01330414495
   PubMed Web of Science ®Google Scholar
• Verry C, Sancey L, Dufort S, et al. Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a Phase I study protocol. BMJ Open. 2019;9(2):e023591. doi:10.1136/bmjopen-2018-023591
   PubMed Web of Science ®Google Scholar
• Radiotherapy of Multiple Brain Metastases Using AGuIX® (NANORAD2). https://clinicaltrials.gov/ct2/show/NCT03818386. Accessed 1020, 2020.
   Google Scholar
• Kotb S, Piraquive J, Lamberton F, et al. Safety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates. Sci Rep. 2016:6. doi:10.1038/srep3505328442741
   PubMed Web of Science ®Google Scholar
• Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases (NANOSTEREO) https://clinicaltrials.gov/ct2/show/NCT04094077?term=NCT04094077&draw=2&rank=1. Accessed 1020, 2020.
   Google Scholar
• Lux F, Tran VL, Thomas E, et al. AGuIX ® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine. The British Journal of Radiology. 2018:20180365. doi:10.1259/bjr.2018036530226413
   PubMed Web of Science ®Google Scholar
• Maeda H, Sano Y, Takeshita J, et al. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin: theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery. Cancer Chemother Pharmacol. 1981;5(4):243–249. doi:10.1007/BF004343926455212
   PubMed Web of Science ®Google Scholar
• Sparreboom A. Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol). Clin Cancer Res. 2005;11(11):4136–4143. doi:10.1158/1078-0432.CCR-04-229115930349
   PubMed Web of Science ®Google Scholar
• Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. 2015;91:3–6. doi:10.1016/j.addr.2015.01.00225579058
   PubMed Web of Science ®Google Scholar
• Bort G, Lux F, Dufort S, Crémillieux Y, Verry C, Tillement O. EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX nanoparticles. Theranostics. 2020;10(3):1319–1331. doi:10.7150/thno.3754331938067
   PubMed Web of Science ®Google Scholar
• Sun S, Lei Y, Li Q, et al. Neuropilin-1 is a glial cell line-derived neurotrophic factor receptor in glioblastoma. Oncotarget. 2017;8(43):74019–74035. doi:10.18632/oncotarget.1863029088765
   PubMedGoogle Scholar
• Hamerlik P, Lathia JD, Rasmussen R, et al. Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med. 2012;209(3):507–520. doi:10.1084/jem.2011142422393126
   PubMed Web of Science ®Google Scholar
• Caponegro MD, Moffitt RA, Tsirka SE. Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas. Oncotarget. 2018;9(86):35655–35665. doi:10.18632/oncotarget.2627330479695
   PubMedGoogle Scholar
• Lyons M, Phang I, Eljamel S. The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy. Photodiagnosis Photodyn Ther. 2012;9(1):40–45. doi:10.1016/j.pdpdt.2011.12.00122369727
   PubMed Web of Science ®Google Scholar
• Muragaki Y, Akimoto J, Maruyama T, et al. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. Journal of Neurosurgery. 2013;119(4):845–852. doi:10.3171/2013.7.JNS1341523952800
   PubMed Web of Science ®Google Scholar
• Shimizu K, Nitta M, Komori T, et al. Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study. Front Neurol. 2018;9:24. doi:10.3389/fneur.2018.0002429441040
   PubMed Web of Science ®Google Scholar
• Dupont C, Vermandel M. INtraoperative photoDYnamic Therapy for GliOblastomas: study Protocol for a Phase. Clin Trial. 2018;6.
   Google Scholar
• Bechet D, Mordon SR, Guillemin F, Barberi-Heyob MA. Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies. Cancer Treat Rev. 2014;40(2):229–241. doi:10.1016/j.ctrv.2012.07.00422858248
   PubMed Web of Science ®Google Scholar
• Calixto GMF, Bernegossi J, de Freitas LM, Fontana CR, Chorilli M. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules. 2016;21(3):3. doi:10.3390/molecules21030342
   Web of Science ®Google Scholar
• Toussaint M, Pinel S, Auger F, et al. Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma. Theranostics. 2017;7(2):436–451. doi:10.7150/thno.1721828255341
   PubMed Web of Science ®Google Scholar
• Bechet D, Auger F, Couleaud P, et al. Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI. Nanomedicine. 2015;11(3):657–670. doi:10.1016/j.nano.2014.12.00725645959
   PubMed Web of Science ®Google Scholar
• Thomas E, Colombeau L, Gries M, et al. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma. Int J Nanomedicine. 2017;12:7075–7088. doi:10.2147/IJN.S14155929026302
   PubMed Web of Science ®Google Scholar
• Youssef Z, Yesmurzayeva N, Larue L, et al. New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy. Journal of Clinical Medicine. 2019;8(12):2205. doi:10.3390/jcm8122205
   PubMed Web of Science ®Google Scholar
• Kamarulzaman EE, Vanderesse R, Gazzali AM, et al. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application. J Biomol Struct Dyn. 2017;35(1):26–45. doi:10.1080/07391102.2015.113119626766582
   PubMed Web of Science ®Google Scholar
• Kamarulzaman EE, Mohd Gazzali A, Acherar S, et al. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy. Int J Mol Sci. 2015;16(10):24059–24080. doi:10.3390/ijms16102405926473840
   PubMed Web of Science ®Google Scholar
• Bouzerar R, Chaarani B, Gondry-Jouet C, Zmudka J, Balédent O. Measurement of choroid plexus perfusion using dynamic susceptibility MR imaging: capillary permeability and age-related changes. Neuroradiology. 2013;55(12):1447–1454. doi:10.1007/s00234-013-1290-224150596
   PubMed Web of Science ®Google Scholar
• Truillet C, Lux F, Tillement O, Dugourd P, Antoine R. Coupling of HPLC with Electrospray Ionization Mass Spectrometry for Studying the Aging of Ultrasmall Multifunctional Gadolinium-Based Silica Nanoparticles. Anal Chem. 2013;85(21):10440–10447. doi:10.1021/ac402429p24160370
   PubMed Web of Science ®Google Scholar
• Zhou Y, Dai Z. New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy. Chem Asian J. 2018;13(22):3333–3340. doi:10.1002/asia.20180014929441706
   PubMed Web of Science ®Google Scholar
• Thomas N, Bechet D, Becuwe P, et al. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo. J Photochem Photobiol B. 2009;96(2):101–108. doi:10.1016/j.jphotobiol.2009.04.00819464192
   PubMed Web of Science ®Google Scholar
• Tirand L, Frochot C, Vanderesse R, et al. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J Controlled Release. 2006;111(1–2):153–164. doi:10.1016/j.jconrel.2005.11.017
   PubMed Web of Science ®Google Scholar
• Bechet D, Tirand L, Faivre B, et al. Neuropilin-1 Targeting Photosensitization-Induced Early Stages of Thrombosis via Tissue Factor Release. Pharm Res. 2010;27(3):468–479. doi:10.1007/s11095-009-0035-820087632
   PubMed Web of Science ®Google Scholar
• Bantz C, Koshkina O, Lang T, et al. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions. Beilstein J Nanotechnol. 2014;5:1774–1786. doi:10.3762/bjnano.5.18825383289
   PubMed Web of Science ®Google Scholar
• Millart E, Lesieur S, Faivre V. Superparamagnetic lipid-based hybrid nanosystems for drug delivery. Expert Opin Drug Deliv. 2018;15(5):523–540. doi:10.1080/17425247.2018.145380429543082
   PubMed Web of Science ®Google Scholar
• Sancey L, Kotb S, Truillet C, et al. Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection. ACS Nano. 2015;9(3):2477–2488. doi:10.1021/acsnano.5b0055225703068
   PubMed Web of Science ®Google Scholar
• Pasquini L, Napolitano A, Visconti E, et al. Gadolinium-Based Contrast Agent-Related Toxicities. CNS Drugs. 2018;32(3):229–240. doi:10.1007/s40263-018-0500-129508245
   PubMed Web of Science ®Google Scholar
• Le Duc G, Roux S, Paruta-Tuarez A, et al. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment. Cancer Nanotechnol. 2014;5(1):1. doi:10.1186/s12645-014-0004-826561509
   PubMedGoogle Scholar
• Mignot A, Truillet C, Lux F, et al. A Top-Down Synthesis Route to Ultrasmall Multifunctional Gd-Based Silica Nanoparticles for Theranostic Applications. Chem Eur J. 2013;19(19):6122–6136. doi:10.1002/chem.20120300323512788
   PubMed Web of Science ®Google Scholar
• Tissue expression of NRP1 - Summary - The Human Protein Atlas. Accessed 71, 2020 https://www.proteinatlas.org/ENSG00000099250-NRP1/tissue.
   Google Scholar
• Richeri A, Vierci G, Martínez GF, Latorre MP, Chalar C, Brauer MM. Neuropilin-1 receptor in the rapid and selective estrogen-induced neurovascular remodeling of rat uterus. Cell Tissue Res. 2020. doi:10.1007/s00441-020-03196-8
   Web of Science ®Google Scholar
• Guan M, Zhou Y, Liu S, et al. Photo-triggered gadofullerene: enhanced cancer therapy by combining tumor vascular disruption and stimulation of anti-tumor immune responses. Biomaterials. 2019;213:119218. doi:10.1016/j.biomaterials.2019.05.02931136911
   PubMed Web of Science ®Google Scholar
• Czabanka M, Parmaksiz G, Bayerl SH, et al. Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies. Eur J Cancer. 2011;47(8):1276–1284. doi:10.1016/j.ejca.2011.02.00121396810
   PubMed Web of Science ®Google Scholar
• Acker G, Palumbo A, Neri D, Vajkoczy P, Czabanka M. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth. J Neurooncol. 2016;129(1):33–38. doi:10.1007/s11060-016-2143-827188647
   PubMed Web of Science ®Google Scholar
• Denysenko T, Gennero L, Roos MA, et al. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell Biochem Funct. 2010;28(5):343–351. doi:10.1002/cbf.166620535838
   PubMed Web of Science ®Google Scholar
• Miyauchi JT, Caponegro MD, Chen D, Choi MK, Li M, Tsirka SE. Deletion of Neuropilin 1 from Microglia or Bone Marrow–Derived Macrophages Slows Glioma Progression. Cancer Res. 2018;78(3):685–694. doi:10.1158/0008-5472.CAN-17-143529097606
   PubMed Web of Science ®Google Scholar
• Pyonteck SM, Akkari L, Schuhmacher AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264–1272. doi:10.1038/nm.333724056773
   PubMed Web of Science ®Google Scholar
• Jackson CM, Lim M, Drake CG. Immunotherapy for Brain Cancer: recent Progress and Future Promise. Clin Cancer Res. 2014;20(14):3651–3659. doi:10.1158/1078-0432.CCR-13-205724771646
   PubMed Web of Science ®Google Scholar
• Miyauchi JT, Chen D, Choi M, et al. Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression. Oncotarget. 2016;7(9):9. doi:10.18632/oncotarget.6877
   Google Scholar